Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 88: 1597-1600, 2000;
8750-7587/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (30)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banzett, R. B.
Right arrow Articles by Moosavi, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banzett, R. B.
Right arrow Articles by Moosavi, S. H.
Vol. 88, Issue 5, 1597-1600, May 2000

Simple contrivance "clamps" end-tidal PCO2 and PO2 despite rapid changes in ventilation

Robert B. Banzett1,2, Ronald T. Garcia1, and Shakeeb H. Moosavi1

1 Physiology Program, Harvard School of Public Health, Boston 02115; and 2 Department of Medicine, Harvard Medical School, West Roxbury Brockton Veterans Affairs Medical Center, Boston, Massachusetts 02132


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS AND DISCUSSION
REFERENCES

The device described in this study uses functionally variable dead space to keep effective alveolar ventilation constant. It is capable of maintaining end-tidal PCO2 and PO2 within ±1 Torr of the set value in the face of increases in breathing above the baseline level. The set level of end-tidal PCO2 or PO2 can be independently varied by altering the concentration in fresh gas flow. The device comprises a tee at the mouthpiece, with one inlet providing a limited supply of fresh gas flow and the other providing reinspired alveolar gas when ventilation exceeds fresh gas flow. Because the device does not depend on measurement and correction of end-tidal or arterial gas levels, the response of the device is essentially instantaneous, avoiding the instability of negative feedback systems having significant delay. This contrivance provides a simple means of holding arterial blood gases constant in the face of spontaneous changes in breathing (above a minimum alveolar ventilation), which is useful in respiratory experiments, as well as in functional brain imaging where blood gas changes can confound interpretation by influencing cerebral blood flow.

hypercapnia; alveolar ventilation; brain imaging; functional magnetic response imaging; positron emission tomography


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS AND DISCUSSION
REFERENCES

THE DESIGN PRESENTED IS A convenient way to keep end-tidal PCO2 (PETCO2) and PO2 constant, even in the case of rapidly changing ventilation. Such a device is useful in several experimental circumstances, for instance when it is desired to have subjects voluntarily increase respiratory frequency (f) or tidal volume (VT) to examine perceptual consequences (e.g., Ref. 4) or to test respiratory muscle performance (e.g., Ref. 2). In other circumstances, breathing may change spontaneously (e.g., because of anxiety) and can cause undesirable secondary effects, which confound interpretation of the experiment. A prime example of this is found in modern techniques for functional brain imaging. Positron emission tomography and functional magnetic resonance imaging are techniques to measure local cerebral metabolism, thus inferring neural activity. Both techniques depend on changes in cerebral blood flow (1), which is strongly influenced by arterial PCO2 (3). This contrivance also makes it convenient to measure steady-state ventilatory response to CO2, as the desired CO2 level is more easily maintained in the face of consequent changes in ventilation.

Sommer et al. (6) recently described a device that reduces changes in alveolar gases during hyperpnea. Our device, like theirs, limits the amount of fresh gas inspired and supplies additional gas containing higher PCO2 and lower PO2 for any additional ventilation. The Sommer et al. device, however, supplies additional gas from a tank containing an approximation of "average" alveolar gas composition, whereas our device supplies the actual alveolar gas expired on the previous breath, thus providing somewhat more precise regulation. Our device not only automatically adjusts for small (±10%) differences in resting PETCO2 or end-tidal PO2 among subjects but also allows us to make intentional large changes in PCO2 (or PO2) and hold each new level constant.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS AND DISCUSSION
REFERENCES

Overview. The subject expires into a large tube that serves as an alveolar gas reservoir. Inspiratory gas initially comes from a bag reservoir supplied by a high-impedance constant-flow source. As the subject continues inspiration after the fresh gas from the bag has been exhausted, pressure drops in the system, and a spring-loaded valve at the distal end of the alveolar gas reservoir opens. The subject is thus able to breathe in more gas, but its composition is identical to alveolar gas. The minimum alveolar ventilation at which this device will hold constant PCO2 is the alveolar ventilation, which establishes PCO2 with no inspired CO2.

Contrivance design. The contrivance, depicted in Fig. 1, comprises a manifold (T piece) connected to two tubes and a mouthpiece (or tightly sealed mask). One tube, the fresh gas inspiratory limb, provides gas from a 3-liter anesthetic bag via a one-way valve and a 1-m-long by 3.8-cm-ID tube. Fresh gas from a high-impedance flow (e.g., compressed gas tanks) is continuously fed to the anesthetic bag via a flowmeter; the flow through this meter determines the amount of inspired fresh gas or effective alveolar ventilation. The resistance of the line from bag to mouthpiece should be as low as possible. Depending on the requirements of the experiment, the fresh gas can be air, oxygen, or some other oxygen-containing blend to suit the requirements of the experiment (see Varying gas concentration below). In our laboratory, inspired fresh gas is heated and humidified (SCT 3000 Marquest Medical Products), and expiratory tubing is insulated to minimize cooling and condensation.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic of contrivance. See text for detailed description. Pneumotachometers (P-Tach A and B) are not essential to the function of the system. Tube that forms the reservoir for expired gas is truncated. Solid arrowheads, steady flow; open arrowheads, cyclic flow; arrows with solid lines, inspiratory flow; arrows with dashed lines, expiration.

The other tube connected to the T piece, the expiratory/rebreathing limb, consists of a tube 3.5 m long by 3.8 cm ID that forms a reservoir holding ~4 liters of expired gas. The distal end of this tube terminates in a second T piece. One port of this T piece is attached to a standard one-way valve, allowing expiration (Hans Rudolph model 5710). The other port of the T piece is attached to a rebreathing control valve that allows inspiratory flow when a pressure threshold is exceeded. The rebreathing control valve is typically set to open at 1-2 cmH2O; the minimal setting is determined by the pressure drop during inspiration from the uncollapsed bag, which in turn depends on the resistance of the fresh gas line and the inspiratory flow rate. The threshold valve must be set so that it does not open until the reservoir bag collapses; higher settings will not impair the function of the system but will increase the load faced by the subject.

The low-resistance one-way valves used for the inspiratory and expiratory line had an opening pressure <0.1 cmH2O (Hans Rudolph model 5710). The rebreathing control valve (prototype positive end-expiratory pressure valve, Emerson, Cambridge, MA), which controlled the amount of reinspired alveolar gas, had an adjustable threshold (0 to -7.5 cmH2O). Figure 2 shows the flow vs. pressure curves for various opening settings on this valve. The pressure-flow characteristics were determined by employing a flow source (Lewyt vacuum cleaner model 59) connected to the breathing device at the mouthpiece. Pressure was sampled at the mouth end of the valve, referred to atmospheric pressure.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   Pressure-flow characteristic of the rebreathing control valve. Opening pressure and resistance of valve is shown with 5 different spring preload settings. Flow was generated with a variable-controlled vacuum cleaner; each line shows result of slowly increasing power to the vacuum. Leftmost curve is at the usual setting for operation of the system, an opening pressure of 1 cmH2O. VRB, flow permitted by the rebreathing control valve.

Operation of the system. Before the subject is connected to the mouthpiece, a normal resting PETCO2 is measured with a fine nasal cannula while the subject sits quietly (5). It is our experience that subjects almost invariably increase ventilation behaviorally when breathing via a mouthpiece or mask. Thus to achieve normal resting PETCO2 it is necessary to impose some rebreathing, even in the baseline state. After the subject is connected to the mouthpiece, the flow of fresh gas into the anesthetic bag is adjusted such that during baseline there is a small amount of alveolar gas reinspired from the expiratory limb. This should be confirmed both by visual verification that the bag fully collapses and by inspection of the tidal PCO2 or PO2 trace to confirm slight reinspiration of alveolar gas. Because baseline ventilation in the mouthpiece requires some reinspiration to achieve resting PETCO2, the system can maintain constant alveolar concentrations in the face of small decreases in ventilation, as well as large increases in ventilation.

Varying gas concentration. For some experiments, it is desirable to vary alveolar gas concentration. This is easily accomplished by altering the content of the fresh gas supply. We find it convenient to use a gas blender to supply fresh gas (e.g., Siemens model 965). For instance, in an experiment requiring constant normoxia and variable PETCO2, one could blend from a gas cylinder containing 21% O2-balance N2 and a tank containing 15% CO2-21% O2-balance N2. The most rapid rise in PETCO2 is accomplished by giving a few breaths of high inspired PCO2 (PICO2) and then gradually reducing the inspired concentration to the required steady-state level. (In perceptual experiments, we generally avoid PICO2 greater than PETCO2 to minimize possible taste cues.) The most rapid fall in PETCO2 requires not only reducing PICO2 to zero but also temporarily increasing fresh gas flow. In experiments not requiring this speed and precision, inspired gas flow could simply be switched between two fixed concentrations.

Safety precautions. It is standard practice in our laboratory never to connect any gas supply to the breathing apparatus that does not contain adequate oxygen to support life. It is also routine to monitor arterial saturation with a pulse oximeter whenever a subject is connected to any breathing circuit.

Test of efficacy. We tested the system's ability to maintain constant PETCO2 by instructing subjects to target breathing to a metronome at various frequencies while they were being coached to breathe at particular VT values. This provided a range of ventilations from 5 to 60 l/min achieved with eight different combinations of VT and f by using VT values of 0.5-3 liters and f values of 10-40 breaths/min. Transitions between patterns of ventilation were made within a few breaths, and each new pattern was held for 3 min during which PETCO2 was monitored for deviations from the set level.

Measurements and recordings. Subjects breathed via the mouthpiece and wore a nose clip. Tidal PCO2 and PO2 were monitored continuously (Datex-Engstrom Cardio Cap II). Flow was sampled at the mouth and at the rebreathing control valve (Fleisch Pneumotachograph no. 2. and Validyne MP45 with 2-cmH2O diaphragm). Airway opening pressure was measured at the mouthpiece (Validyne MP45 with 56-cmH2O diaphragm). Analog signals were digitized at a sample rate of 20 samples · s-1 · channel-1 and recorded by using data-acquisition software (Windaq/200, DATAQ Instruments, Akron, OH).


    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS AND DISCUSSION
REFERENCES

Efficacy. Fig. 3 shows pertinent pressures, flows, and tidal gases during a range of conditions of VT and f voluntarily achieved by one subject. In steady-state conditions, the system was capable of maintaining PETCO2 within ±2 Torr of baseline in the worst case of five subjects tested, and ±1 Torr was the typical performance. We also examined performance when the system was challenged by two- to fivefold rapid transitions between levels of ventilation. We used as a measure of performance the variability of PETCO2 during the 20 breaths surrounding transitions. The worst case showed a standard deviation of 1 Torr, and the best, 0.2 Torr. Median standard deviation of 25 transitions was 0.5 Torr. Typical transitions are shown in Fig. 4. Our measurements show improved precision of PETCO2 regulation over those of Sommer et al. (6), but we do not know whether operation of their system could be further improved.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   System variables during 5 breathing patterns generated voluntarily by the subject. VTOT, flow at the mouth; VRB, reinspired alveolar gas flow from reservoir (i.e., flow permitted by rebreathing control valve, which was set at 1-cmH2O opening pressure); PAW, airway opening pressure measured at the mouth; PCO2, concentration of CO2 measured at the mouthpiece. Tracing shows steady end-tidal level (defined by dotted line) and shows evidence of reinspired CO2 during inspiration. Panels a, b, and c: tidal volume was constant at 1 liter and frequency increased from 10 to 15 to 20 breaths/min, respectively. Panels c and d: frequency was constant at 20 breaths/min and tidal volume changed from 1 to 2 liters. Panels d and e: tidal volume was constant at 2 liters and frequency decreased from 20 to 10 breaths/min. Panels c and e: same ventilation (20 l/min) achieved with very different tidal volume-frequency combinations. Data span the range from 10 to 40 l/min. Inspiratory pressure peaks range from -2 to -4 cmH2O. Note that VRB increases with increasing ventilation, whether due to frequency or tidal volume change.



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4.   Typical examples of rapid changes (Delta ) in ventilation. Each breath is represented by 1 data point. Top: change from 12 to 70 l/min, accomplished by increasing tidal volume (VT) from 0.5 to 3 liters at constant respiratory frequency (f). Bottom: change from 26 to 16 l/min accomplished by decreasing f from 30 to 19 breaths/min at constant VT. Notice that end-tidal PCO2 is essentially unchanged throughout these transitions.

We also note that PETCO2 can be raised to a new steady-state level within a few breaths by using high levels of inspired CO2, but the return to baseline can be slow, if one simply returns inspired CO2 to zero, because alveolar ventilation is limited by design. If it is desired to lower PETCO2 more rapidly, it is possible to temporarily increase the flow of fresh gas (after noting the flow to which to return).

Limitations. This device is relatively insensitive to changes in VT and f, because most of the fresh gas is inspired first; however, neither the present device nor that of Sommer et al. (6) can prevent a rise in PETCO2 if the subject reduces real alveolar ventilation below minimum alveolar ventilation. This may occur if the subject reduces minute ventilation, or if the subject adopts a breathing pattern of very small VT with high f, so that much of the fresh gas penetrates no further than the anatomic dead space. Whereas this pattern of breathing is unphysiological in humans, it implies that the device will not work in animals that pant (although the problem should be ameliorated by the effects of high-f mixing). Furthermore, these devices do not automatically adapt to changes in metabolic CO2 production.

Subjects did detect a slight added resistance to breathing, as would be predicted from psychophysical data (7). Many subjects could detect the change in pressure as the bag collapsed and the rebreathing control valve opened. We were able to keep inspiratory pressure drops below a level objectionable to most subjects. This required careful attention to the minimization of impedance in the fresh gas limb so that the rebreathing control valve threshold could be set to <2 cmH2O, typically 1 cmH2O. If necessary for a particular experiment, the impedance of both limbs of the device could be reduced further.

Troubleshooting common problems. This system has been in use in our laboratory for 2 yr. We encountered several problems while setting up and learning to use this device. Most problems result in a fall in PETCO2 at high ventilation. Possible causes are as follows. 1) VT in large subjects may exceed the volume of the expired gas reservoir; this is easily remedied by extending the length of the reservoir tube. 2) Inward leaks (especially when a face mask is used) compromise operation by allowing added fresh gas into the system. 3) The threshold valve may open prematurely because of a) valve malfunction or b) excessive resistance in the fresh gas line, which causes the pressure drop to exceed threshold before the bag collapses. This malfunction can be detected by setting fresh air flow just above minute ventilation (so the bag does not fully collapse) and observing whether PCO2 remains zero throughout inspiration. 4) There is excessive fresh gas flow at baseline.

Another common problem is excessive pressure drop or pressure fluctuation during inspiration (usually brought to our attention by the subject). Possible causes are as follows: 1) sticky valves; 2) high resistance of inspiratory limb requiring a high opening pressure setting for rebreathing control valve; and 3) excessive mass of rebreathing control valve flapper can create a resonant system interacting with the inertance or compliance of the gas in the alveolar reservoir. We first tried rebreathing control valves with weight thresholds and found them unsuitable for this reason.

Conclusion. The contrivance presented here is simple to implement, provides somewhat more precise regulation of end-tidal gases than previous designs, and conveniently allows one end-tidal gas to be independently varied.


    ACKNOWLEDGEMENTS

We thank our subjects for their time and cooperation and George Emerson of J. H. Emerson Company for designing and constructing a prototype valve to meet our specifications.


    FOOTNOTES

This study was supported by National Heart, Lung, and Blood Institute Grant HL-46690.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: R. B. Banzett, Physiology Program, Dept. of Environmental Health, Harvard School of Public Health, 665 Huntington Ave., Boston, MA 02115-6021.

Received 27 December 1999; accepted in final form 3 January 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS AND DISCUSSION
REFERENCES

1.   Kwong, KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, Kennedy DN, Hoppel BE, Cohen MS, and Turner R. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 89: 5675-5679, 1992[Abstract/Free Full Text].

2.   Leith, D, and Bradley M. Ventilatory muscle strength and endurance training. J Appl Physiol 41: 508-516, 1976[Abstract/Free Full Text].

3.   Ramsay, SC, Murphy K, Shea SA, Friston KJ, Lammertsma AA, Clark JC, Adams L, Guz A, and Frackowiak RS. Changes in global cerebral blood flow in humans: effect on regional cerebral blood flow during a neural activation task. J Physiol (Lond) 471: 521-534, 1993[Abstract/Free Full Text].

4.   Remmers, JE, Brooks J, and Tenney SM. Effect of controlled ventilation on the tolerable limit of hypercapnia. Respir Physiol 4: 78-90, 1968[ISI][Medline].

5.   Shea, SA, Walter J, Murphy K, and Guz A. Evidence for individuality of breathing patterns in resting healthy man. Respir Physiol 68: 331-344, 1987[ISI][Medline].

6.   Sommer, LZ, Iscoe S, Robicsek A, Kruger J, Silverman J, Rucker J, Dickstein J, Volgyesi GA, and Fisher JA. A simple breathing circuit minimizing changes in alveolar ventilation during hyperpnoea. Eur Respir J 12: 698-701, 1998[Abstract].

7.   Zechman, FW, Jr, and Wiley RL. Afferent inputs to breathing: respiratory sensation. In: Handbook of Physiology. The Respiratory System. Control of Breathing. Bethesda, MD: Am. Physiol. Soc, 1986, sect. 3, vol. II, pt. 1, chapt. 14, p. 449-474.


J APPL PHYSIOL 88(5):1597-1600
8570-7587/00 $5.00 Copyright © 2000 the American Physiological Society



This article has been cited by other articles:


Home page
J. Physiol.Home page
B. W. Wilkins, T. L. Pike, E. A. Martin, T. B. Curry, M. L. Ceridon, and M. J. Joyner
Exercise intensity-dependent contribution of {beta}-adrenergic receptor-mediated vasodilatation in hypoxic humans
J. Physiol., February 15, 2008; 586(4): 1195 - 1205.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. H. Simmons, J. M. Manson, and J. R. Halliwill
Mild central chemoreflex activation does not alter arterial baroreflex function in healthy humans
J. Physiol., September 15, 2007; 583(3): 1155 - 1163.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. H. Simmons, C. T. Minson, J.-L. Cracowski, and J. R. Halliwill
Systemic hypoxia causes cutaneous vasodilation in healthy humans
J Appl Physiol, August 1, 2007; 103(2): 608 - 615.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Slessarev, J. Han, A. Mardimae, E. Prisman, D. Preiss, G. Volgyesi, C. Ansel, J. Duffin, and J. A. Fisher
Prospective targeting and control of end-tidal CO2 and O2 concentrations
J. Physiol., June 15, 2007; 581(3): 1207 - 1219.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. W. Wilkins, W. G. Schrage, Z. Liu, K. C. Hancock, and M. J. Joyner
Systemic hypoxia and vasoconstrictor responsiveness in exercising human muscle
J Appl Physiol, November 1, 2006; 101(5): 1343 - 1350.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. E. Meadows, F. Kotajima, A. Vazir, K. Kostikas, A. K. Simonds, M. J. Morrell, and D. R. Corfield
Overnight Changes in the Cerebral Vascular Response to Isocapnic Hypoxia and Hypercapnia in Healthy Humans: Protection Against Stroke
Stroke, November 1, 2005; 36(11): 2367 - 2372.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Iscoe and J. A. Fisher
Hyperoxia-Induced Hypocapnia: An Underappreciated Risk
Chest, July 1, 2005; 128(1): 430 - 433.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. H. Moosavi, R. B. Banzett, and J. P. Butler
Time course of air hunger mirrors the biphasic ventilatory response to hypoxia
J Appl Physiol, December 1, 2004; 97(6): 2098 - 2103.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. E. Meadows, D. M. O'Driscoll, A. K. Simonds, M. J. Morrell, and D. R. Corfield
Cerebral blood flow response to isocapnic hypoxia during slow-wave sleep and wakefulness
J Appl Physiol, October 1, 2004; 97(4): 1343 - 1348.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. D. Gilmore, C. Hudson, S. T. Venkataraman, D. Preiss, and J. Fisher
Comparison of Different Hyperoxic Paradigms to Induce Vasoconstriction: Implications for the Investigation of Retinal Vascular Reactivity
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3207 - 3212.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. J. Weisbrod, P. R. Eastwood, G. O'Driscoll, J. H. Walsh, M. Best, J. R. Halliwill, and D. J. Green
Vasomotor Responses to Hypoxia in Type 2 Diabetes
Diabetes, August 1, 2004; 53(8): 2073 - 2078.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. M. O'Driscoll, G. E. Meadows, D. R. Corfield, A. K. Simonds, and M. J. Morrell
Cardiovascular response to arousal from sleep under controlled conditions of central and peripheral chemoreceptor stimulation in humans
J Appl Physiol, March 1, 2004; 96(3): 865 - 870.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. C. McKay, K. C. Evans, R. S. J. Frackowiak, and D. R. Corfield
Neural correlates of voluntary breathing in humans
J Appl Physiol, September 1, 2003; 95(3): 1170 - 1178.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. H. Moosavi, E. Golestanian, A. P. Binks, R. W. Lansing, R. Brown, and R. B. Banzett
Hypoxic and hypercapnic drives to breathe generate equivalent levels of air hunger in humans
J Appl Physiol, January 1, 2003; 94(1): 141 - 154.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. W. LANSING, B. S.-H. IM, J. I. THWING, A. T. R. LEGEDZA, and R. B. BANZETT
The Perception of Respiratory Work and Effort Can Be Independent of the Perception of Air Hunger
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1690 - 1696.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (30)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banzett, R. B.
Right arrow Articles by Moosavi, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banzett, R. B.
Right arrow Articles by Moosavi, S. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online